サンプル依頼リスト カート
  • English
表紙：マイクロニードルドラッグデリバリー市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2023年～2030年）- 製品別、技術別、グレード別、用途別、エンドユーザー別、地域別
市場調査レポート
商品コード
1312400

マイクロニードルドラッグデリバリー市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2023年～2030年）- 製品別、技術別、グレード別、用途別、エンドユーザー別、地域別

Microneedle Drug Delivery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region:
出版日: | 発行: Fairfield Market Research | ページ情報: 英文 220 Pages | 納期: 2～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
マイクロニードルドラッグデリバリー市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2023年～2030年）- 製品別、技術別、グレード別、用途別、エンドユーザー別、地域別
出版日: 2023年07月17日
発行: Fairfield Market Research
ページ情報: 英文 220 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のマイクロニードルドラッグデリバリー市場について調査し、市場の概要とともに、製品別、技術別、グレード別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 規制シナリオ
  • 技術の進歩
  • マイクロニードルアレイの研究出版物の傾向分析（2000年～2019年）
  • 臨床試験分析
  • 上市済みマイクロニードルベースの経皮型製品
  • 特許リスト
  • COVID-19の影響分析

第3章 世界のマイクロニードルドラッグデリバリーの見通し、2018年～2030年

  • 世界のマイクロニードルドラッグデリバリー市場の見通し、製品別、2018年～2030年
  • 世界のマイクロニードルドラッグデリバリー市場の見通し、用途別、2018年～2030年
  • 世界のマイクロニードルドラッグデリバリー市場の見通し、地域別、2018年から2030年

第4章 北米のマイクロニードルドラッグデリバリー市場の見通し、2018年～2030年

第5章 欧州のマイクロニードルドラッグデリバリー市場の見通し、2018年～2030年

第6章 アジア太平洋のマイクロニードルドラッグデリバリー市場の見通し、2018年～2030年

第7章 ラテンアメリカのマイクロニードルドラッグデリバリー市場の見通し、2018年～2030年

第8章 中東・アフリカのマイクロニードルドラッグデリバリー市場の見通し、2018年～2030年

第9章 競合情勢

  • 市場シェア分析、2022年
  • 企業プロファイル
    • 3M Corp.
    • Becton, Dickinson and Company
    • Corium International Inc.
    • CosMED Pharmaceutical Co. Ltd.
    • Debiotech
    • Derma spark
    • NanoPass Inc.
    • Sanofi Pasteur
    • TheraJect Inc.
    • Valeritas Inc.
    • Zosano Pharma Inc.

第10章 付録

目次

The global healthcare industry is witnessing a transformative shift in drug delivery methods, particularly in the field of transdermal drug administration. The conventional approach of hypodermic needles for injections has long been associated with various risks such as needle injuries, pain perception, and limitations of skin transport barriers. In this context, microneedle arrays (MNA) have emerged as an ideal solution for minimally invasive and painless drug delivery through the skin, bypassing the stratum corneum and disrupting the traditional drug delivery landscape.

Microneedles Minimize Patient Trypanophobia, Paving the Way for Immunisation Programs

Microneedle drug delivery offers several advantages, including faster onset, improved efficacy, and higher patient compliance. By providing therapeutic benefits and delivering reproducible results with pinpoint accuracy and minimal variability in bioavailability, microneedles are revolutionizing drug delivery methods. One of the significant advantages of microneedles is their ability to minimize patient trypanophobia, which is the fear of needles. This aspect is increasing adoption rates in the paediatrics segment and bolstering mass immunisation programs. With higher efficiency in drug delivery control compared to other transdermal methods, microneedles are shaping the future of drug administration.

Microneedle Companies Collaborate with Vaccine Manufacturers to Ensure Success

Leading players in the microneedle drug delivery market, such as NanoPass Technologies, are collaborating with immunotherapy companies to leverage their proprietary MicronJet technology in the development of affordable, effective, and safe COVID-19 vaccines. Other prominent companies in the market include 3M, Microdermics, Zosano Pharma Corporation (ZSAN), Nitto Denko Corporation, Becton, Dickinson and Company, Vaxxas Pty Ltd, Valeritas (Zealand Pharma A/S), Corium, Inc., TheraJect, Inc., LTS Lohmann Therapie-Systeme AG, and Alza Corporation. The shared intellectual property between these companies and vaccine manufacturers is expected to play a pivotal role in ensuring successful drug delivery.

Versatility of Microneedle Arrays Enables Innovative Drug Delivery Solutions

The demand for therapies where active substances are not effectively absorbed through oral administration has driven the innovation of newer nanoparticle and microparticle drug encapsulation technologies. Transdermal administration, especially with ovalbumin as the most common protein antigen for immunisation studies using microneedle arrays, has shown immense promise. Microneedles have also garnered significant interest in the cosmetics and diagnostics industries, with clinical trials being conducted for wearable epidermal diagnostic devices. The unique attributes of microneedle arrays allow them to open up limitless opportunities for rectal, oral, ocular, and buccal drug delivery.

Low Manufacturing Cost Fuels Popularity of Hollow Microneedle Arrays

The microneedle drug delivery market offers various fabrication options, including dissolving, hollow, hydrogel, and solid microneedle arrays. While solid microneedles made from silicon or metal are well-established and have a longer product lifespan, polymer microneedle arrays have witnessed significant growth in recent years. Hollow microneedle arrays are particularly favored due to their precise drug control, low cost, and ease of manufacturing. These attributes contribute to their popularity and widespread use in the microneedle drug delivery market.

As the global healthcare industry continues to emphasize innovation and patient-centric drug delivery methods, microneedle arrays are set to play a pivotal role in revolutionizing transdermal drug administration.

Table of Contents

1. Executive Summary

  • 1.1. Global Microneedle Drug Delivery Market Outlook, 2018 - 2030 (US$ Million)
  • 1.2. Global Microneedle Drug Delivery Market Incremental Opportunity, 2018 - 2030 (US$ Million)
  • 1.3. Key Industry Trends

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
      • 2.2.1.1. Driver 1
      • 2.2.1.2. Driver 2
    • 2.2.2. Restraints
      • 2.2.2.1. Restraint 1
      • 2.2.2.2. Restraint 2
    • 2.2.3. Opportunities
      • 2.2.3.1. Opportunity 1
      • 2.2.3.2. Opportunity 2
  • 2.3. Regulatory Scenario
  • 2.4. Technological Advancements
  • 2.5. Microneedle Array Research Publications Trend Analysis (2000-2019)
  • 2.6. Clinical Trials Analysis
  • 2.7. Marketed microneedle-based transdermal products
  • 2.8. List of patents by :
    • 2.8.1. Microneedle array technologies
    • 2.8.2. Fabrication of mold
    • 2.8.3. Therapeutic drugs delivered
  • 2.9. COVID-19 Impact Analysis

3. Global Microneedle Drug Delivery Outlook, 2018 - 2030

  • 3.1. Global Microneedle Drug Delivery Market Outlook, By Product, 2018 - 2030
    • 3.1.1. Key Highlights
    • 3.1.2. Global Microneedle Drug Delivery Market Outlook, by Product, Value (US$ Million), 2018 - 2030
      • 3.1.2.1. Coated Microneedles
      • 3.1.2.2. Dissolving Microneedles
      • 3.1.2.3. Hollow Microneedles
      • 3.1.2.4. Hydrogel Microneedles
      • 3.1.2.5. Solid Microneedles
    • 3.1.3. Global Microneedle Drug Delivery Market Share and BPS Analysis, by Product, 2023 and 2030
    • 3.1.4. Global Microneedle Drug Delivery Market Attractiveness Analysis, by Product, 2023 - 2030
  • 3.2. Global Microneedle Drug Delivery Market Outlook, By Application, 2018 - 2030
    • 3.2.1. Key Highlights
    • 3.2.2. Global Microneedle Drug Delivery Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 3.2.2.1. Bio-macromolecule Delivery
      • 3.2.2.2. Combination Therapy
      • 3.2.2.3. Diagnostics
      • 3.2.2.4. Drug Delivery
      • 3.2.2.5. Ocular Drug Delivery
      • 3.2.2.6. Vaccine & Gene Delivery
    • 3.2.3. Global Microneedle Drug Delivery Market Share and BPS Analysis, by Application, 2023 and 2030
    • 3.2.4. Global Microneedle Drug Delivery Market Attractiveness Analysis, by Application, 2023 - 2030
  • 3.3. Global Microneedle Drug Delivery Market Outlook, By Region, 2018 - 2030
    • 3.3.1. Key Highlights
    • 3.3.2. Global Microneedle Drug Delivery Market Outlook, by Region, Value (US$ Million), 2018 - 2030
      • 3.3.2.1. North America
      • 3.3.2.2. Europe
      • 3.3.2.3. Asia Pacific
      • 3.3.2.4. Latin America
      • 3.3.2.5. Middle East & Africa
    • 3.3.3. Global Microneedle Drug Delivery Market Share and BPS Analysis, by Region, 2023 and 2030
    • 3.3.4. Global Microneedle Drug Delivery Market Attractiveness Analysis, by Region, 2023 - 2030

4. North America Microneedle Drug Delivery Market Outlook, 2018 - 2030

  • 4.1. North America Microneedle Drug Delivery Market Outlook, By Product, 2018 - 2030
    • 4.1.1. Key Highlights
    • 4.1.2. North America Microneedle Drug Delivery Market Outlook, by Product, Value (US$ Million), 2018 - 2030
      • 4.1.2.1. Coated Microneedles
      • 4.1.2.2. Dissolving Microneedles
      • 4.1.2.3. Hollow Microneedles
      • 4.1.2.4. Hydrogel Microneedles
      • 4.1.2.5. Solid Microneedles
    • 4.1.3. North America Microneedle Drug Delivery Market Share and BPS Analysis, by Product, 2023 and 2030
  • 4.2. North America Microneedle Drug Delivery Market Outlook, By Application, 2018 - 2030
    • 4.2.1. Key Highlights
    • 4.2.2. North America Microneedle Drug Delivery Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 4.2.2.1. Bio-macromolecule Delivery
      • 4.2.2.2. Combination Therapy
      • 4.2.2.3. Diagnostics
      • 4.2.2.4. Drug Delivery
      • 4.2.2.5. Ocular Drug Delivery
      • 4.2.2.6. Vaccine & Gene Delivery
    • 4.2.3. North America Microneedle Drug Delivery Market Share and BPS Analysis, by Application, 2023 and 2030
  • 4.3. North America Microneedle Drug Delivery Market Outlook, By Country, 2018 - 2030
    • 4.3.1. Key Highlights
    • 4.3.2. North America Microneedle Drug Delivery Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 4.3.2.1. U.S.
      • 4.3.2.2. Canada
    • 4.3.3. North America Microneedle Drug Delivery Market Share and BPS Analysis, by Country, 2023 and 2030

5. Europe Microneedle Drug Delivery Market Outlook, 2018 - 2030

  • 5.1. Europe Microneedle Drug Delivery Market Outlook, By Product, 2018 - 2030
    • 5.1.1. Key Highlights
    • 5.1.2. Europe Microneedle Drug Delivery Market Outlook, by Product, Value (US$ Million), 2018 - 2030
      • 5.1.2.1. Coated Microneedles
      • 5.1.2.2. Dissolving Microneedles
      • 5.1.2.3. Hollow Microneedles
      • 5.1.2.4. Hydrogel Microneedles
      • 5.1.2.5. Solid Microneedles
    • 5.1.3. Europe Microneedle Drug Delivery Market Share and BPS Analysis, by Product, 2023 and 2030
  • 5.2. Europe Microneedle Drug Delivery Market Outlook, By Application, 2018 - 2030
    • 5.2.1. Key Highlights
    • 5.2.2. Europe Microneedle Drug Delivery Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 5.2.2.1. Bio-macromolecule Delivery
      • 5.2.2.2. Combination Therapy
      • 5.2.2.3. Diagnostics
      • 5.2.2.4. Drug Delivery
      • 5.2.2.5. Ocular Drug Delivery
      • 5.2.2.6. Vaccine & Gene Delivery
    • 5.2.3. Europe Microneedle Drug Delivery Market Share and BPS Analysis, by Application, 2023 and 2030
  • 5.3. Europe Microneedle Drug Delivery Market Outlook, By Country, 2018 - 2030
    • 5.3.1. Key Highlights
    • 5.3.2. Europe Microneedle Drug Delivery Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 5.3.2.1. Germany
      • 5.3.2.2. France
      • 5.3.2.3. U.K.
      • 5.3.2.4. Italy
      • 5.3.2.5. Spain
      • 5.3.2.6. Russia
      • 5.3.2.7. Rest of Europe
    • 5.3.3. Europe Microneedle Drug Delivery Market Share and BPS Analysis, by Country, 2023 and 2030

6. Asia Pacific Microneedle Drug Delivery Market Outlook, 2018 - 2030

  • 6.1. Asia Pacific Microneedle Drug Delivery Market Outlook, By Product, 2018 - 2030
    • 6.1.1. Key Highlights
    • 6.1.2. Asia Pacific Microneedle Drug Delivery Market Outlook, by Product, Value (US$ Million), 2018 - 2030
      • 6.1.2.1. Coated Microneedles
      • 6.1.2.2. Dissolving Microneedles
      • 6.1.2.3. Hollow Microneedles
      • 6.1.2.4. Hydrogel Microneedles
      • 6.1.2.5. Solid Microneedles
    • 6.1.3. Asia Pacific Microneedle Drug Delivery Market Share and BPS Analysis, by Product, 2023 and 2030
  • 6.2. Asia Pacific Microneedle Drug Delivery Market Outlook, By Application, 2018 - 2030
    • 6.2.1. Key Highlights
    • 6.2.2. Asia Pacific Microneedle Drug Delivery Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 6.2.2.1. Bio-macromolecule Delivery
      • 6.2.2.2. Combination Therapy
      • 6.2.2.3. Diagnostics
      • 6.2.2.4. Drug Delivery
      • 6.2.2.5. Ocular Drug Delivery
      • 6.2.2.6. Vaccine & Gene Delivery
    • 6.2.3. Asia Pacific Microneedle Drug Delivery Market Share and BPS Analysis, by Application, 2023 and 2030
  • 6.3. Asia Pacific Microneedle Drug Delivery Market Outlook, By Country, 2018 - 2030
    • 6.3.1. Key Highlights
    • 6.3.2. Asia Pacific Microneedle Drug Delivery Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 6.3.2.1. Japan
      • 6.3.2.2. China
      • 6.3.2.3. India
      • 6.3.2.4. Australia & New Zealand
      • 6.3.2.5. South Korea
      • 6.3.2.6. Rest of Asia Pacific
    • 6.3.3. Asia Pacific Microneedle Drug Delivery Market Share and BPS Analysis, by Country, 2023 and 2030

7. Latin America Microneedle Drug Delivery Market Outlook, 2018 - 2030

  • 7.1. Latin America Microneedle Drug Delivery Market Outlook, By Product, 2018 - 2030
    • 7.1.1. Key Highlights
    • 7.1.2. Latin America Microneedle Drug Delivery Market Outlook, by Product, Value (US$ Million), 2018 - 2030
      • 7.1.2.1. Coated Microneedles
      • 7.1.2.2. Dissolving Microneedles
      • 7.1.2.3. Hollow Microneedles
      • 7.1.2.4. Hydrogel Microneedles
      • 7.1.2.5. Solid Microneedles
    • 7.1.3. Latin America Microneedle Drug Delivery Market Share and BPS Analysis, by Product, 2023 and 2030
  • 7.2. Latin America Microneedle Drug Delivery Market Outlook, By Application, 2018 - 2030
    • 7.2.1. Key Highlights
    • 7.2.2. Latin America Microneedle Drug Delivery Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 7.2.2.1. Bio-macromolecule Delivery
      • 7.2.2.2. Combination Therapy
      • 7.2.2.3. Diagnostics
      • 7.2.2.4. Drug Delivery
      • 7.2.2.5. Ocular Drug Delivery
      • 7.2.2.6. Vaccine & Gene Delivery
    • 7.2.3. Latin America Microneedle Drug Delivery Market Share and BPS Analysis, by Application, 2023 and 2030
  • 7.3. Latin America Microneedle Drug Delivery Market Outlook, By Country, 2018 - 2030
    • 7.3.1. Key Highlights
    • 7.3.2. Latin America Microneedle Drug Delivery Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 7.3.2.1. Brazil
      • 7.3.2.2. Mexico
      • 7.3.2.3. Argentina
      • 7.3.2.4. Rest of Latin America
    • 7.3.3. Latin America Microneedle Drug Delivery Market Share and BPS Analysis, by Country, 2023 and 2030

8. Middle East & Africa Microneedle Drug Delivery Market Outlook, 2018 - 2030

  • 8.1. Middle East & Africa Microneedle Drug Delivery Market Outlook, By Product, 2018 - 2030
    • 8.1.1. Key Highlights
    • 8.1.2. Middle East & Africa Microneedle Drug Delivery Market Outlook, by Product, Value (US$ Million), 2018 - 2030
      • 8.1.2.1. Coated Microneedles
      • 8.1.2.2. Dissolving Microneedles
      • 8.1.2.3. Hollow Microneedles
      • 8.1.2.4. Hydrogel Microneedles
      • 8.1.2.5. Solid Microneedles
    • 8.1.3. Middle East & Africa Microneedle Drug Delivery Market Share and BPS Analysis, by Product, 2023 and 2030
  • 8.2. Middle East & Africa Microneedle Drug Delivery Market Outlook, By Application, 2018 - 2030
    • 8.2.1. Key Highlights
    • 8.2.2. Middle East & Africa Microneedle Drug Delivery Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 8.2.2.1. Bio-macromolecule Delivery
      • 8.2.2.2. Combination Therapy
      • 8.2.2.3. Diagnostics
      • 8.2.2.4. Drug Delivery
      • 8.2.2.5. Ocular Drug Delivery
      • 8.2.2.6. Vaccine & Gene Delivery
    • 8.2.3. Middle East & Africa Microneedle Drug Delivery Market Share and BPS Analysis, by Application, 2023 and 2030
  • 8.3. Middle East & Africa Microneedle Drug Delivery Market Outlook, By Country, 2018 - 2030
    • 8.3.1. Key Highlights
    • 8.3.2. Middle East & Africa Microneedle Drug Delivery Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 8.3.2.1. Saudi Arabia
      • 8.3.2.2. UAE
      • 8.3.2.3. Israel
      • 8.3.2.4. South Africa
      • 8.3.2.5. Rest of Middle East & Africa
    • 8.3.3. Middle East & Africa Microneedle Drug Delivery Market Share and BPS Analysis, by Country, 2023 and 2030

9. Competitive Landscape

  • 9.1. Market Share Analysis, 2022
  • 9.2. Company Profiles
    • 9.2.1. 3M Corp.
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product Pipeline
      • 9.2.1.4. Recent Developments
    • 9.2.2. Becton, Dickinson and Company
    • 9.2.3. Corium International Inc.
    • 9.2.4. CosMED Pharmaceutical Co. Ltd.
    • 9.2.5. Debiotech
    • 9.2.6. Derma spark
    • 9.2.7. NanoPass Inc.
    • 9.2.8. Sanofi Pasteur
    • 9.2.9. TheraJect Inc.
    • 9.2.10. Valeritas Inc.
    • 9.2.11. Zosano Pharma Inc.

10. Appendix

  • 10.2. Research Methodology
  • 10.3. Report Specific Research Approach
  • 10.4. Acronyms and Abbreviations